BioPharm International's Peer Reviewers: The Editorial Advisory Board - BioPharm International

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
BioPharm International's Peer Reviewers: The Editorial Advisory Board
BioPharm International's Peer Reviewers and Editorial Advisory Board comprises distinguished specialists involved in the biologic manufacture of therapeutic drugs, diagnostics, and vaccines. Members serve as a sounding board for the editors and advise them on biotechnology trends, identify potential contributors, and review manuscripts submitted for publication.

K.A. Ajit-Simh
President
Shiba Associates

Fredric G. Bader
Vice President, Process Sciences
Centocor, Inc.

Rory Budihandojo
Manager, Computer Validation
Boehringer-Ingelheim Chemicals

Edward G. Calamai
Managing Partner
Pharmaceutical Manufacturing and Compliance Associates, LLC

John Carpenter
Professor, School of Pharmacy
University of Colorado Health Sciences Center

Suggy S. Chrai
President and CEO
The Chrai Associates

John Curling
President
John Curling Consulting AB

Rebecca Devine
Biotechnology Consultant

Mark D. Dibner
President
BioAbility

Leonard J. Goren
Global Director, Genetic Identity
Promega Corporation

Uwe Gottschalk
Vice President
Purification Technologies
Sartorius Stedim Biotech GmbH

Rajesh K. Gupta, PhD
Laboratory Chief, Div. of Product Quality, Office of Vaccines Research and Review
Center of Biologics Evaluation and Research, FDA

Chris Holloway
Group Director, Regulatory Affairs
ERA Consulting Group

Ajaz S. Hussain, PhD
Vice-President Biological Systems
Research & Development
Philip Morris International

Jean F. Huxsoll
Senior Director, QA Compliance
Bayer Healthcare Pharmaceuticals

Barbara K. Immel
President
Immel Resources, LLC

Denny Kraichely
Principal Research Scientist
Centocor R&D, Inc.

Stephan O. Krause, PhD
Director of Quality
Mpex Pharmaceuticals, Inc.

Steven S. Kuwahara
Principal Consultant
GXP BioTechnology, LLC

Eric S. Langer
President and Managing Partner
BioPlan Associates, Inc.

Howard L. Levine
President
BioProcess Technology Consultants

Herb Lutz
Senior Consulting Engineer
Millipore Corporation

Hans-Peter Meyer, PhD
VP Lonza Innovation for Future Technologies
Lonza, Ltd.

K. John Morrow
President
Newport Biotech

Barbara Potts
Director, QC Biology
Genentech

Tom Ransohoff
Senior Consultant
BioProcess Technology Consultants

Anurag S. Rathore
Biotech CMC Consultant
Faculty Member, Department of Chemical Engineering
Indian Institute of Technology

Janet Rose Rea
Vice President, Regulatory Affairs & QA
AVI BioPharma

Timothy Schofield
Director, North American Regulatory Affairs
GlaxoSmithKline

Sally S. Seaver
President
Seaver Associates

Paula Shadle, PhD
Principal Consultant
Shadle Consulting

Alexander F. Sito
President
BioValidation

Gail Sofer
Director, Regulatory Compliance
GE Healthcare

S. Joseph Tarnowski
Senior Vice President, Biologics Manufacturing and Process Development
Bristol-Myers Squibb

William R. Tolbert
President
WR Tolbert & Associates

Michiel E. Ultee, PhD
Vice President of Process Sciences
Laureate Pharma

Krish Venkat
Director, Quality Control
Wyeth Biotech

Steven Walfish
President
Statistical Outsourcing services

Gary Walsh
Associate Professor, Department of Chemical and Environmental Sciences and Materials and Surface Science Institute, University of Limerick, Ireland

Lloyd Wolfinbarger
President and Managing Partner
BioScience Consultants, LLC

ADVERTISEMENT

ADVERTISEMENT

Advertiser Gallery
Click here